New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 10, 2014
08:17 EDTNWBONorthwest Biotherapeutics initiates Phase III trial of DCVax-L in Germany
Northwest Biotherapeutics announced that it has initiated the Phase III trial of DCVax-L in Germany. The first site to open in Germany was a medical center in Dresden, which was initiated in late May. The Company has now scheduled the full-day site initiations for 3 more sites during June and 4 further sites in July.
News For NWBO From The Last 14 Days
Check below for free stories on NWBO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 19, 2014
10:42 EDTNWBOOptions with decreasing implied volatility
Subscribe for More Information
August 13, 2014
09:32 EDTNWBONorthwest Biotherapeutics says claims by Feuerstein about DCVax trial 'false'
Subscribe for More Information
09:30 EDTNWBONorthwest Biotherapeutics says claims by Feuerstein about DCVax trial 'false'
Subscribe for More Information
August 12, 2014
11:27 EDTNWBONorthwest Bio trial changes 'hint at failure,' TheStreet's Feuerstein says
Subscribe for More Information
August 11, 2014
08:16 EDTNWBONorthwest Biotherapeutics obtains approvals for enhancements of DCVAX trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use